Additionally, some patients may have access to generic or biosimilar versions of GLP-1 medications, which can be more affordable
Medication codes for GLP-1 agonists and insulin were also retrieved
Genetic variation in AKT1 and AKT2 is associated with clinical outcomes following chemotherapy of esophageal cancer
Mechanistically, GLP-1s are thought to cross the blood-brain barrier and act directly on the brain, potentially reducing neuroinflammation, improving insulin signaling, and altering amyloid and tau pathology
So all four of these are almost like molecular sponges for your mitochondria
Une tude de 2002 avait montr qu'un dosage de 3 g/jour augmentait l'oxydation des acides gras mme chez des personnes au mtabolisme normal, sans dficit en carnitine, ce qui suggre qu'un effet biologique existe au-del du simple cas des carencs